Research News and Research

RSS

OriGene Technologies, ISB to create proteotypic PeptideAtlas and SRM/MRM mass spectrometry standard database

OriGene Technologies, Inc., a leading gene-centric life sciences company, and the Institute for Systems Biology (ISB), announce plans to create a proteotypic PeptideAtlas and develop an SRM/MRM (single reaction monitoring, multiple reaction monitoring) mass spectrometry standard database for 5,000 human proteins. The new collaboration will apply ISB's novel systems biology mass spectrometry expertise to OriGene's large collection of full length human proteins.

12 May 2010

Regular exercise plays important role in improving wellbeing of patients with schizophrenia: Review

Regular exercise can play an important a role in improving the physical and mental wellbeing of individuals with schizophrenia, according to a review published in The Cochrane Library.

12 May 2010

Researchers develop new method for tracing carbon flux

Microbial communities are performing important functions all around us - from the earth in our flowerpots to the human gut. Now researchers have developed a method for studying the metabolic functions of microbial communities in detail.

12 May 2010

Researchers develop anti-angiogenic molecule SR16388 for treatment of MM

SRI International, an independent nonprofit research and development organization, announced today that researchers have developed an anti-angiogenic molecule SR16388 that has demonstrated preclinical antitumor activity against multiple myeloma.

12 May 2010

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since 2000, was presented for the 20th time at TECHNOPARK® Zurich. The award is given for technological innovations which - thanks to pioneering entrepreneurial achievements - are about to be launched on the market. This year's award winner is Neurimmune Therapeutics AG, represented by Dr. Jan Grimm, Professor Christoph Hock, Professor Roger Nitsch and Dr. Michael Salzmann.

12 May 2010

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients' blood pressure is closely monitored and controlled, a clinical panel has determined.

12 May 2010

Oncos Therapeutics completes € 4 million investment from HealthCap

Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a € 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding € 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.

12 May 2010

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.

12 May 2010

Gilead Sciences board authorizes $5 billion common stock repurchase program

Gilead Sciences, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock through May 2013.

12 May 2010

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics.

12 May 2010

Colorectal cancer screening rates much lower among African Americans: Study

Among African Americans, colorectal cancer is the third most common cause of cancer-related death. With the proper screening, it has a 90 percent cure rate, yet screening rates are much lower among this group than other ethnic groups.

12 May 2010

Beike Biotechnology, Jiangsu government's CMC open world's largest stem cell management center

Beike Biotechnology Co. Ltd., one of the world's leading biotechnology companies focusing on adult stem cell therapies, and the Jiangsu government's China Medical City (CMC) opened China's state-of-the-art stem cell storage and processing facility today. The 20,000 square-meter Stem Cell Regenerative Medicine Industrial Project of National Bio-Industry Base (NBPD) houses China's first comprehensive regenerative medicine technology center and its largest international stem cell bank.

12 May 2010

New research shows British Indian children have better mental health than British Whites

British Indian children have substantially better mental health than British Whites, new research from the London School of Hygiene & Tropical Medicine shows.

12 May 2010

PharmAthene first-quarter revenue decreases to $3.1 million

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the first quarter ended March 31, 2010.

12 May 2010

Minimum-wage employees more likely to be obese than those who earn higher wages: UC Davis study

A new UC Davis study has found that minimum-wage employees are more likely to be obese than those who earn higher wages, adding to growing evidence that being poor is a risk factor for unhealthy weight.

12 May 2010

Study confirms Resveratrol's impact on cognitive processes of the brain

The subject of extensive studies across the world, Resveratrol is proving to be a major talking point in the scientific community. And as evidence comes to light of the continuing beneficial effects of this compound, a further study by the University of Northumbria in the UK has confirmed what many scientists already believe to be the case - that Resveratrol could have a significant impact on the cognitive processes of the human brain.

12 May 2010

SonarMed AMS technology obtains FDA clearance

SonarMed, a developer and manufacturer of critical care respiratory monitoring technologies, announced that it has received Food and Drug Administration clearance for its patented SonarMed Airway Monitoring System, which monitors breathing tubes for patients requiring ventilators.

12 May 2010

Cardiome Pharma records $15.5M net income for first-quarter 2010

Cardiome Pharma Corp. today reported financial results for the first quarter ended March 31, 2010. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).

12 May 2010

Johns Hopkins Bloomberg School of Public Health awarded Grand Challenges Explorations grant

The Johns Hopkins Bloomberg School of Public Health announced today that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Jason Rasgon, PhD, an assistant professor with the Johns Hopkins Malaria Research Institute, and his research to develop an evolution-proof pesticide for eliminating mosquitoes that transmit malaria to humans.

12 May 2010

OXiGENE reports consolidated net loss of $11.0M for first-quarter 2010

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter ended March 31, 2010, and presented an update on recent clinical and corporate progress.

12 May 2010

Research News and Research

OriGene Technologies, ISB to create proteotypic PeptideAtlas and SRM/MRM mass spectrometry standard database

Regular exercise plays important role in improving wellbeing of patients with schizophrenia: Review

Researchers develop new method for tracing carbon flux

Researchers develop anti-angiogenic molecule SR16388 for treatment of MM

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

Oncos Therapeutics completes € 4 million investment from HealthCap

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Gilead Sciences board authorizes $5 billion common stock repurchase program

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

Colorectal cancer screening rates much lower among African Americans: Study

Beike Biotechnology, Jiangsu government's CMC open world's largest stem cell management center

New research shows British Indian children have better mental health than British Whites

PharmAthene first-quarter revenue decreases to $3.1 million

Minimum-wage employees more likely to be obese than those who earn higher wages: UC Davis study

Study confirms Resveratrol's impact on cognitive processes of the brain

SonarMed AMS technology obtains FDA clearance

Cardiome Pharma records $15.5M net income for first-quarter 2010

Johns Hopkins Bloomberg School of Public Health awarded Grand Challenges Explorations grant

OXiGENE reports consolidated net loss of $11.0M for first-quarter 2010

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News